Aortic Stenosis Clinical Trial
Official title:
Microembolic Signals and Cerebrospinal Fluid Markers of Neuronal Damage After Surgical Aortic Valve
The use of MRI have shown that the incidence of postoperative cerebral lesions due to cerebral embolization is high (1). Nonetheless the extent of postoperative neurological dysfunction is only a fraction of the actual amount of new postoperative changes detected on MRI. Transcranial Doppler (TCD) has shown the occurrence of extensive microembolic signals in intracerebral arteries during open heart procedures (2). The clinical significance of cerebral microemboli is not clear (3-5). The use of serological markers to assess cerebral injury after open cardiac surgery is difficult to interpret. The levels of markers seems to be contaminated from extracerebral sources (6). In order assess the release of markers of neuronal damage after open aortic valve surgery the investigators intend to examine the levels of S-100B, NSE and Tau in cerebrospinal fluid (CSF) by comparing the levels preoperative with the levels one day after surgery. Furthermore the investigators will determine the total amount of cerebral microembolic signals during the surgical procedure by means of TCD. The investigators will statistically test if there is any correlation between the increase in cerebrospinal fluid levels of S-100B,NSE and Tau and the cerebral embolic load.
Patients and clinical procedures 10 patients scheduled for open aortic valve surgery at our
institution will be included into this prospective, observational study. The Human Ethics
Committee of the University of Gothenburg, approved the study protocol. The day before
surgery a lumbar puncture at level L3-4 will be performed using a 27G Whitacre needle. A
sample of 2.5 ml of cerebrospinal fluid will be taken for analysis of S-100B, NSE, Tau and
albumin.
On arrival at OR, standard perioperative monitoring will be established, including an
Auditory Evoked Potential (AEP) monitor for anaesthetic depth measurements (AEP Monitor/2,
Danmeter, Odense, Denmark) and radial arterial and central venous lines. General anaesthesia
is induced with propofol 0.5-1 mg/kg and fentanyl 10 μg/kg. Tracheal intubation will be
facilitated using atracurium 0,5 mg/kg. Sevoflurane is used to maintain an anaesthetic depth
adjusted to an AAI index of 15-30 as recorded by the AEP monitor. Hemodynamic stability will
be obtained by the use of colloidal solution administration, guided by the use of
intra-operative transesophageal echocardiography, and norephineprine to maintain a mean
arterial pressure above 75 mmHg-Also during CPB. A lumbar puncture will be repeated the
first postoperative day repeating the measurement of markers in CSF A certified cardiologist
or anaesthesiologist assess focal neurological impairment before and within 24 hours after
the procedure.
Transcranial Doppler (TCD) By TCD the right medial cerebral artery (RMCA) will be insonated
by the transtemporal approach at a depth of approximately 50 mm using standard criteria. The
investigators use a 2 MHz power M-mode TCD monitor (ST3 ©, Spencer Technologies Seattle,
WA), with the probe fixed in position using a head frame. The Doppler signals will be
continuously monitored and saved to monitor hard drive. Two physicians independently
evaluate the TCD data files offline, and identify microembolic signals (MES) using criteria
for counting emboli signals on spectral and PMD TCD.
Statistical Analysis: Descriptive statistics and tests of normality for continuos data
Correlation analysis; Total cerebral embolic load vs. increase of CSF level S-100B/ NSE/Tau.
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04310046 -
Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial
|
N/A | |
Completed |
NCT03332745 -
Mechanism of Decompensation Evaluation - Aortic Stenosis
|
||
Recruiting |
NCT06008080 -
Post-Market Clinical Follow Up Study With Navitor Valve
|
||
Recruiting |
NCT06055751 -
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
|
||
Active, not recruiting |
NCT04815785 -
Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve System in Patients With Severe Calcific Aortic Stenosis
|
N/A | |
Terminated |
NCT02202434 -
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
|
N/A | |
Recruiting |
NCT03029026 -
The Role of Occult Cardiac Amyloid in the Elderly With Aortic Stenosis.
|
||
Active, not recruiting |
NCT02903420 -
A Clinical Trial of Transcatheter Aortic Valves in Dialysis Patients (Japan)
|
N/A | |
Completed |
NCT02629328 -
CardioCel Tri-leaflet Repair Study
|
N/A | |
Completed |
NCT02306226 -
Symetis ACURATE Neo™ Valve Implantation SAVI TF Registry
|
||
Completed |
NCT01676727 -
ADVANCE Direct Aortic Study
|
||
Withdrawn |
NCT01648309 -
Neuropsychological Testing in Patients Undergoing Transvascular Aortic Valve Implantation
|
N/A | |
Completed |
NCT01422044 -
Risk Prediction in Aortic Stenosis
|
N/A | |
Withdrawn |
NCT00774657 -
Ventricular Remodeling In Patients With Aortic Stenosis Assessed Echocardiography
|
N/A | |
Terminated |
NCT00535899 -
Speckle Tracking Imaging in Patients With Low Ejection Fraction Aortic Stenosis (SPArKLE-AS)
|
N/A | |
Terminated |
NCT05070130 -
OpSens PRIME CLASS
|
||
Completed |
NCT03314857 -
China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population
|
N/A | |
Completed |
NCT04157920 -
Impact of Predilatation Between Self-expanding Valves
|
N/A | |
Enrolling by invitation |
NCT06212050 -
Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
|
||
Recruiting |
NCT05893082 -
Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
|
N/A |